| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8527b9e7a75d6fc0fa63772b0a69f3c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6855
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6829 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68 |
| filingDate |
2018-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_981f1ba80c83a9bfc9a55a1f116e85e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae6fdb02c662696ef3984727a8fea870
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86e5afbd78b5f9779753cb03bf04d6b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1590a320e5cd37663a3263578756702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71a3358ebdaa2bfa84a68bbaa1b501eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3876bee4a4a13dd3f4cd7a1bd17779b2 |
| publicationDate |
2019-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3555117-A2 |
| titleOfInvention |
Modified microcystins and nodularins |
| abstract |
The invention relates to a compound, which comprises the cytotoxic agents microcystin and nodularin. More specifically, the invention is related to a modified microcystin and/or nodularin compound comprising one or more modified substrates, wherein one or more modified substrates comprise an anchor group directly accessible or transformable for use in conjugation chemistry (incl. click chemistry), for the attachment of a targeting moiety. This invention is in the field of cancer treatment. It is in the field of toxins for use in cancer treatment. The modified cytotoxic agents may be used for the therapy of various diseases. |
| priorityDate |
2017-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |